Professional Documents
Culture Documents
RESUMEN
En marzo de 2020, la Organización Mundial de la Salud (OMS) declaró como pandemia a la enfermedad
causada por el virus SARS-CoV2, conocida como COVID-19. El mundo del deporte acompaña y sufre los efectos
INTRODUCTION DIAGNOSE
On March 2020, the World Health Organization (WHO) declared A diagnostic suspicion arises from a clinical-epidemiological inves-
a pandemic state by the disease caused by the SARS-CoV2 known as tigation and physical exam. It is important to question about travelling
COVID-19. The sports community take part in the global effects from this and close contact to sick people. The etiological diagnose to identify
disease. Many competitions were postponed or cancelled, including the the SARS-CoV2 virus is made using techniques such as RT-PCR point of
Olympic Games from Tokyo. Besides that, training facilities were closed care or sorologic rapid test either validated for reference institutions1.
and the athletes had to adapt their training schedules. The most frequent laboratorial finding is lymphopenia. Elevated levels
of lattice dehydrogenase (LDH) and ferritin are common and variation
TRANSMISSION in hepatic enzymes are observed as well. High levels of D-dimer and
The disease is transmitted from person to person mainly by respi- severe lymphopenia seems to be related to an increase in mortality risk1.
ratory droplets. When an infected individual coughs, sneezes or speaks In radiology, bilateral infiltration and ground-glass opacities, mainly
he releases the virus and can contaminate other one when the droplets basal, peripheral and posterior, are the most described findings in thoracic
get in touch to mucous membranes. The transmission can also occurs X-ray and tomography, respectively1.
in case someone touches a contaminated surface and then moves his
hands to eyes, nose or mouth, since there is evidence that the virus stays TREATMENT AND VACCINE
viable in many surfaces for hours to days1. The treatment of COVID-19 depends from patient’s clinical presenta-
tion and risk factors. Patients without viral pneumonia or hypoxia could
SYMPTOMS be treated in a home based care, focusing in prevention measures and
COVID-19 has a widely clinical presentation varying from asymp- monitoring the symptoms. The clinical support is directed to hydration
tomatic to severe infection. According to World Health Organization and use of antithermic medication and analgesics, if necessary1,2.
(WHO), most patients (almost 80%) will be asymptomatic or will present Some patients could develop more severe disease and will have to take
mild symptoms. Approximately 20% will need hospital attendance due hospital attendance with oxygen therapy. Until now there is no specific
to breath shortness and from those ones 5% could need ventilatory treatment approved. WHO and the Centre of Disease Control (CDC) do
support. Some risk factor have been identified in the development not recommend the use of glucocorticoids unless there is another spe-
of severe disease, as age > 60 years, heart disease, decompensated or cific recommendation for its use. A large number of ongoing studies are
severe pneumopathy, immunosuppression, diabetes, kidney diseases, exploring the antiviral treatment, but the drug’s efficacy is still lacking. The
obesity and risky pregnancy1. hydroxichloriquine and chloroquine have been reported as potentially in
The virus incubation period varies from 2 up to 14 days. The symptoms vitro inhibitors of SARS-CoV2. Other drugs as remdesivir, lopinavir-ritonavir,
mostly appears after 5 days from the exposition. Studies shows that an IL-6 inhibitors and convalescent plasma are also being tested1.
infected person could transmit the virus during the asymptomatic period. Vaccines are still in a development phase and should not be avai-
This suggests the transmission can occur even without the emergence lable until 2021.
from any symptom. The most common symptoms are fever (83-99%),
cough (59-82%), fatigue (44-70%), anorexia (40-84%), dyspnea (31-40%) DISCHARGE CRITERIA
and myalgia (11-35%). Other symptoms like sore throat, headache, rhi- The CDC strategy for end of isolation is based on availability of tests.
norrhea, diarrhea, anosmia and ageusia were also reported. The main Test based strategy:
complication is the acute respiratory distress syndrome1. • Absence of fever without any medication; and
372 Rev Bras Med Esporte – Vol. 26, No 5 – Set/Out, 2020
• Improvement of respiratory symptoms; and illness5. Besides that, it is not possible to blame exercise as the only
• Two negative consecutive COVID-19 tests in 24h intervals. responsible for this immunossupressive state. Other factors such as
Strategy when tests aren’t available: sleep, nutrition, emotional stress and environmental exposition could
• At least seven days of isolation after symptoms onset; and be as relevant as physical activity.
• Absence of symptoms for at least three days without using any an- Nieman proposes a relationship between exercise intensity and the
tipyretic medication1,2. infection risk in a way that it presents itself as a J shaped curve, with
Ways to contain dissemination: isolation and prevention the extremities representing the higher risk of illness3. Considering the
confinement context, we should look after the immunological effects
COVID-19 is thought to disseminate by respiratory droplets and
of lowering the intensity of physical activity or the physical inactivity.
because people get close to an infected person. Usually the symptoms
Posteriorly, Gleeson6 proposed that the curve should be flattened, ar-
are present, although the asymptomatic ones are capable to spread
guing there is some difference in clinical evidence between sedentary
the virus. Therefore, the best measure to prevent the disease is to avoid
and physical active (moderate) people. Than in moderate intensity
exposition to the virus. The following measures are recommended to
and volume of exercise, the curve is flatten (Figure 1). On the other
shorten the transmission:
• Wash your hand using soap and water for 20 seconds, or use disinfec- hand, Malm considered that athletes are capable of increasing exercise
tants or alcohol 60% as an alternative. Do this after touching objects intensity and volume without increasing infection risk. By this thought,
and surfaces; we got an S shaped curve, including athletes as a group in which the
• Cover your nose or mouth when you sneeze or cough; immunological system can tolerate extreme exercise conditions without
• Avoid touching your face, specially nose, eyes and mouth; increasing the risk of infection. Therefore, the elite athletic population is
• Don’t share personal objects; less susceptible to illness than general population7.
• Don’t get close to sick people; An International Olympic Committee Consensus suggests that either
• Keep the environment well ventilated; high or low exercise intensity could be associated with increased risk of
• Avoid crowded spaces and keep 2 meters distance from other people; illness5. A study with elite cyclists in Denmark shown less NK cells activity
• After new data about transmission, is recommended the use of cloth during winter, when there is lower training volume8. We still can find
masks that can be made at home with low cost materials. reports of reduction in NK cells levels8, lower levels and proliferation of
Most countries are adopting social distance as a public health measure. lymphocytes, increase in granulocytes levels, reduction in monocytes
This and other measures when properly taken show a positive association levels and an increase in T senescent levels9. By the same way, there are
in reducing the spread of virus transmission and allow the government reports that physical inactivity is associated with an accumulation of
entities to expand the structure and capacity of the health system1. visceral adipose tissue followed by a persistent inflammatory state9. This
chronic inflammation is involved with insulinic resistance, atherosclerosis,
POST-COVID-19 CONSEQUENCES FOR SPORT COMMUNITY neurodegeneration and tumor growth10.
As the whole world get affected, also the sport community feel The stress related to social isolation and confinement could dys-
the effects of the COVID-19 pandemic. The health management team regulate the hippotalamus-pitutary-adrenal axis (HPA) producing in-
has the responsibility to guide and to take care of athletes and staff crease in cortisol levels11. When chronically elevated this hormone has
members promoting prevention from getting ill and keeping them negative effects on the immunity and the immune cells activity. Studies
safe when returning to train after the isolation period. If any athlete got evidence that high cortisol levels are related to reduction in NK cells
the COVID-19 it is expected to have a mild clinical presentation, since activity, impaired response from T lymphocytes12 and altered levels of
they are mostly young and without previous diseases. However, chronic pro-inflammatory citokynes, as TNF-α, IL-1 e IFN-γ13.
complications as post infection myocarditis are possible. Therefore the
sport physician is challenged to define how long an athlete that had Gleeson, M. 2006
Nieman, D. C. 1994
Risk of upper respiratory tract
COVID-19 should be removed from training and when to allow the full
participation. As SARS-CoV2 is a new virus this answers are lacking and
infection
AUTHORS’ CONTRIBUTIONS: Each author made significant individual contributions to this manuscript. ACRC: writing, intellectual concept of the article and revision; FCJ: writing,
revision of the article and intellectual concept; TC: literature review and writing; JMMF, RS, FF, RF, MH, AAW, GP and RA: writing; PB: design of the work, literature review and writing;
FB and AI: writing and revision. All the authors read and approved the final version of the article.
REFERENCES
1. Centers for Disease Control and Prevention. 2019 Novel coronavirus, Wuhan, China. Information for 11. Hawkley LC, Cole SW, Capitanio JP, Norman GJ, Cacioppo JT. Effects of social isolation on
Healthcare Professionals. [Internet]. [acesso em 2020 abr 10]. Disponível em: https://www.cdc.gov/ glucocorticoid regulation in social mammals. Horm Behav. 2012;62(3):314-23.
coronavirus/2019-nCoV/hcp/index.html 12. Kiecolt-Glaser JK, Ricker D, George J, Messick G, Speicher CE, Garner W, et al. Urinary cortisol
2. Toresdahl BG, Asif IM. Coronavirus Disease 2019 (COVID-19): considerations for the competitive levels, cellular immunocompetency, and loneliness in psychiatric inpatients. Psychosom
athlete. Sports Health. 2020; 12(3):221-4. Med. 1984;46(1):15-23.
3. Nieman DC. Exercise, infection and immunity. Int J Sports Med. 1994;15 (Suppl 3):S131-41. 13. Flammer JR, Rogatsky I. Minireview: glucocorticoids in autoimmunity: unexpected targets
and mechanisms. Mol Endocrinol. 2011;25(7):1075-86.
4. Gleeson M. Immune Function in Sport and Exercise. J Appl Physiol (1985). 2007;103(2):693-9.
14. Burke LM. Energy needs of athletes. Can J Appl Physiol. 2001;26(Suppl 1):S202-l9.
5. Soligard T, Schwellnus M, Alonso JM, Bahr R, Clarsen B, Dijkstra HP, et al. How Much Is Too
15. Associação Brasileira de Nutrição (ASBRAN). Guia para uma alimentação saudável em tempos de
Much? (Part 1) International Olympic Committee Consensus Statement on Load in Sport and
COVID-19. 2020.
Risk of Injury. Br J Sports Med. 2016;50(17):1030-41.
16. Bermon S, Castell LM, Calder PC, Bishop NC, Blomstrand E, Mooren FC, et al. Consensus statement:
6. Gleeson M. Immune system adaptation in elite athletes. Curr Opin Clin Nutr Metab Care. 2006;9(6):659-65.
immunonutrition and exercise. Exerc Immunol Rev. 2017;23:8-50.
7. Malm C. Susceptibility to infections in elite athletes: the S-curve. Scand J Med Sci Sports. 2006;16(1):4-6.
17. Bishop NC, Walsh NP, Haines DL, Richards EE, Gleeson M. Pre-exercise carbohydrate status
8. Tvede N, Steensberg J, Baslund B, Kristensen JH, Pedersen BK. Cellular immunity in highly-trained and immune responses to prolonged cycling: II. Effect on plasma cytokine concentration. Int
elite racing cyclists and controls during periods of training with high and low intensity. Scand J Sport Nutr Exerc Metab. 2001;11:503-12.
J Sports Med. 1991;1(3):163-6. 18. Walsh NP. Recommendations to maintain immune health in athletes. Eur J Sport
9. Hoff P, Belavý DL, Huscher D, Lang A, Hahne M, Kuhlmey AK, et al. Effects of 60-day bed Sci. 2018;18(6):820-31.
rest with and without exercise on cellular and humoral immunological parameters. Cell Mol 19. De Pablo MA, De Cienfuegos GA. Modulatory effects of dietary lipids on immune system functions.
Immunol. 2015;12(4):483-92. Immunol Cell Biol. 2000;78(1):31-9.
10. Walsh NP, Gleeson M, Shephard RJ, Gleeson M, Woods JA, Bishop NC, et al. Position statement. 20. Hosomi K, Kunisawa J. Diversity of energy metabolism in immune responses regulated by
Part one: immune function and exercise. Exerc Immunol Rev. 2011;17:6-63. micro-organisms and dietary nutrition. Int Immunol. 2020;32(7):447-54.